SAN DIEGO, Calif., Oct. 17, 2017 -- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it will publish financial results for the third quarter 2017 after the close of market on Thursday, November 2, 2017. Management will discuss the Company’s operations and financial results in a conference call beginning at 2:00 p.m. Pacific (5:00 p.m. Eastern).
Analysts and institutional investors may participate on the conference call by dialing 866-393-0674, referencing the call by ID number 1146136. The general public may access the conference call by dialing 877-344-3935, or on the day of the event visit www.kratosdefense.com for a simultaneous webcast. A replay of the webcast will be available on the Kratos website approximately two hours after the conclusion of the conference call.
About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops transformative, affordable technology for the Department of Defense and commercial customers. Kratos is changing the way breakthrough technologies for these industries are brought to market through proactive research and a streamlined development process. Kratos specializes in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, training and combat systems. For more information, go to www.kratosdefense.com.
Press Contact:
Yolanda White
858-812-7302 Direct
Investor Information:
877-934-4687
[email protected]


Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



